BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37441519)

  • 1. Plasma lipidomic profiling of thiopurine-induced leukopenia after NUDT15 genotype-guided dosing in Chinese IBD patients.
    Li P; Chao K; Hu Z; Qin L; Yang T; Mao J; Zhu X; Hu P; Wang X; Gao X; Huang M
    Front Nutr; 2023; 10():1138506. PubMed ID: 37441519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y; Naito T; Onodera M; Kuroha M; Kimura T; Shiga H; Endo K; Negoro K; Kinouchi Y; Shimosegawa T
    Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Chao K; Wang X; Cao Q; Qian J; Wu K; Zhu X; Yang H; Liang J; Lin L; Huang Z; Zhang Y; Huang Y; Sun Y; Xue X; Huang M; Hu P; Lan P; Gao X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1592-1599. PubMed ID: 28570428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
    J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
    Kakuta Y; Kinouchi Y; Shimosegawa T
    J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.
    Asada A; Nishida A; Shioya M; Imaeda H; Inatomi O; Bamba S; Kito K; Sugimoto M; Andoh A
    J Gastroenterol; 2016 Jan; 51(1):22-9. PubMed ID: 26590936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Yu N; Sriranganathan D; Walker GJ; Sazonovs A; Wilding H; Roberts C; Kennedy NA; Ahmad T; Boyapati RK; Ding NS; Segal JP
    J Crohns Colitis; 2023 Dec; 17(12):1920-1930. PubMed ID: 37346013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD.
    Zhu X; Chao K; Yang T; Wang XD; Guan S; Tang J; Xie W; Yu AM; Yang QF; Li M; Yang HS; Diao N; Hu PJ; Gao X; Huang M
    Clin Pharmacol Ther; 2022 Dec; 112(6):1236-1242. PubMed ID: 36002392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of
    Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
    World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Sato T; Takagawa T; Kakuta Y; Nishio A; Kawai M; Kamikozuru K; Yokoyama Y; Kita Y; Miyazaki T; Iimuro M; Hida N; Hori K; Ikeuchi H; Nakamura S
    Intest Res; 2017 Jul; 15(3):328-337. PubMed ID: 28670229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population.
    Khoo XH; Wong SY; Ibrahim NRW; Ng RT; Chew KS; Lee WS; Wong ZQ; Raja Ali RA; Shahrani S; Leow AH; Hilmi IN
    Front Med (Lausanne); 2022; 9():880937. PubMed ID: 35991642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between the
    Liu Y; Meng Y; Wang L; Liu Z; Li J; Dong W
    Onco Targets Ther; 2018; 11():8309-8317. PubMed ID: 30538500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease.
    Chao K; Huang Y; Zhu X; Tang J; Wang X; Lin L; Guo H; Zhang C; Li M; Yang Q; Huang J; Ye L; Hu P; Huang M; Cao Q; Gao X
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1124-1133. PubMed ID: 34563096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.
    van Gennep S; Konté K; Meijer B; Heymans MW; D'Haens GR; Löwenberg M; de Boer NKH
    Aliment Pharmacol Ther; 2019 Sep; 50(5):484-506. PubMed ID: 31342537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis.
    Cargnin S; Genazzani AA; Canonico PL; Terrazzino S
    Pharmacol Res; 2018 Sep; 135():102-111. PubMed ID: 30048756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.